Literature DB >> 3027433

Anti-fibrotic effect of malotilate on liver fibrosis induced by carbon tetrachloride in rats.

S Igarashi, T Hatahara, Y Nagai, H Hori, K Sakakibara, M Katoh, A Sakai, T Sugimoto.   

Abstract

The effect of malotilate on liver fibrosis of rat induced by carbon tetrachloride (CCl4) was studied. CCl4 was given subcutaneously (1.5 ml/kg) to male Wistar rats twice a week for 11 weeks. Administration of malotilate (100 mg/kg) 5 times a week was started in the 5th experimental week and continued thereafter. The biochemical parameters in serum such as concentration of total protein and transaminase activities were improved by malotilate administration. The livers treated with CCl4 only were atrophic and markedly nodular, and histologically, severe collagen deposition and pseudolobular formation were observed. However, the livers treated with CCl4 and malotilate showed only slight accumulation of collagen fibers although hypertrophic and fatty metamorphosis was observed. Immunocytochemically, type I and type III collagens were stained in livers from rats treated with CCl4 only and rats treated with CCl4 and malotilate, but stainability was rather weak in the latter. The increased amount of hydroxyproline in the liver and that excreted into urine were markedly suppressed by malotilate administration. The levels of protocollagen prolyl hydroxylase activity in the liver were almost the same in CCl4-treated and CCl4 and malotilate-treated rats. However, the levels of collagenolytic enzyme activity were slightly higher in the latter. From these results, anti-fibrotic action of malotilate was clear and involvement of enhanced collagenolytic enzyme activity was suggested.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3027433

Source DB:  PubMed          Journal:  Jpn J Exp Med        ISSN: 0021-5031


  2 in total

1.  Effects of fibril- or fixed-collagen on matrix metalloproteinase-1 and tissue inhibitor of matrix metalloproteinase-1 production in the human hepatocyte cell line HLE.

Authors:  Makoto Nakamuta; Kazuhiro Kotoh; Munechika Enjoji; Hajime Nawata
Journal:  World J Gastroenterol       Date:  2005-04-21       Impact factor: 5.742

2.  Effects of malotilate treatment on the serum markers of hepatic fibrogenesis in liver cirrhosis.

Authors:  S Takase; A Takada; M Yasuhara; H Sato; Y Matsuda
Journal:  Gastroenterol Jpn       Date:  1988-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.